graphic
graphic  
graphic
News > Companies
graphic
Cubist shares soar
Cubist Pharm. says it will submit new drug application for new antibiotic.
March 7, 2002: 4:00 p.m. ET

graphic NEW YORK (CNN/Money) - Shares of Cubist Pharmaceuticals Inc. rose more than 25 percent Thursday after the company said it is prepared to file a New Drug Application for its antibiotic Cidecin.

Cubist said it has received correspondence from the U.S. Food and Drug Administration indicating that the NDA for Cidecin would be reviewed and accepted.

graphic
graphic graphic
graphic
If approved, the Lexington, Mass.-based company said it would launch the drug in 2003.

Cidecin is the first in a new class of antibiotics, lipopeptides. Cubist is first seeking approval for the drug to treat skin and soft tissue infections, but the company is also conducting Phase III clinical trials for the drug's treatment of community-acquired pneumonia and other infections.

graphic  
Cidecin would be the first drug on the market for Cubist. The company plans to market the drug itself in the United States, and has a partnership with Foster City, Calif.-based Giliad Sciences Inc. (GILD: down $1.36 to $71.84, Research, Estimates).

Cubist is also negotiating for a partner to market the drug in Japan. graphic





  graphic


© 2010 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2010 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.
graphic